Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Tuberculosis (Edinb). 2020 Apr 2;122:101935. doi: 10.1016/j.tube.2020.101935

Table 3.

Effect modification between diabetes and pre-diabetes with high IFN-gamma TB antigen (≥10 IU/mL) among strata of tuberculin skin test results, N=513

Effect of diabetes status on TB antigen within levels of TST** Mean antigen, lU/mL (95%CI) Mean TST induration, mm (95%CI) TB antigen ≥10 IU/mL % (95%CI) Crude odds ratio ≥10 IU/mL (95%CI) Adjusted odds ratio* ≥10 IU/mL (95%CI)
TST positive, N=208 (induration 10 mm)
Diabetes 5.3 (3.6, 7.0) 15.2 (14.1, 16.2) 34.1 (17.1, 51.1) 1.4 (0.5, 3.7) 1.4 (0.5, 3.5)
Pre-diabetes 5.9 (4.6, 7.1) 15.7 (15.1, 16.2) 41.2 (26.9, 55.4) 1.8 (0.8, 4.0) 1.7 (0.7, 4.1)
Euglycemic 5.1 (4.1, 6.1) 16.2 (15.5, 17.0) 27.5 (18.1, 37.0) REF REF
TST negative, N=202 (induration <10mm)
Diabetes 3.3 (2.0, 4.6) 1.9 (0.8, 2.9) 14.0 (0.7, 27.2) 3.6 (0.8, 16.4) 4.8 (1.0, 22.0)
Pre-diabetes 2.2 (1.3, 3.1) 2.0 (0.9, 3.2) 6.9 (0.0, 14.0) 1.6 (0.4, 7.2) 1.7 (0.4, 7.0)
Euglycemic 1.7 (1.2, 2.2) 1.5 (0.6, 2.3) 4.3 (0.2, 8.5) REF REF
TST not done, N=103 (QFT positive)
Diabetes 3.9 (1.9, 5.8) NA 20.6 (2.2, 39.0) 2.9 (0.4, 20.0) 4.0 (0.6, 29.1)
Pre-diabetes 5.0 (3.6, 6.4) NA 18.7 (7.7, 29.8) 2.6 (0.6, 10.9) 2.2 (0.4, 10.9)
Euglycemic 3.1 (1.4, 4.7) NA 8.2 (0.0, 18.0) REF REF

Table 3 Abbreviations TST: tuberculin skin test; QFT: QuantiFERON®-TB Gold-In-Tube

*

Adjusted for age, sex, history of active TB

**

Likelihood ratio p-value for interaction term between TST status and diabetes status =0.63

Bold indicates 95% confidence interval estimate did not include null value